CMPX

Compass Therapeutics, Inc.

Insiders buying nowCIK 1738021

Compass Therapeutics, Inc. insider trading

Insiders at Compass Therapeutics, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Lerner Neil (Chief Accounting Officer) buying $2.8K of CMPX, filed Sep 25, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.

Bought on the open market
$2.8K
Sold
—
Insiders
1
Latest trade
Sep 24, 2026

From SEC filings · last 30 days

Recent CMPX insider transactions

  1. Lerner NeilChief Accounting Officer

    Bought 2,500 sh at $1.14 · Sep 24, 2026

    $2.8K

    Filing

SEC Form 4 data, Q3 2024 to Q2 2026

CMPX insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded CMPX on the open market: 5 purchases worth $155.9K and 1 sale worth $5.7M. In the last four quarters alone: 2 purchases ($75.6K) and 0 sales, by 2 insiders.

QuarterBoughtSold
Q2 2026+$75.6K2 buys—
Q1 2026——
Q4 2025——
Q3 2025——
Q2 2025+$80.3K3 buys−$5.7M1 sale
Q1 2025——
Q4 2024——
Q3 2024——
Largest purchase
+$47.3K of CMPX by Anderman Jonathan (General Counsel) on Apr 29, 2026.
Largest sale
−$5.7M of CMPX by Gordon Carl L (Director · 10% Owner) on Apr 09, 2025.

Open-market transactions through Jun 30, 2026most recent first

  • Anderman Jonathan

    General Counsel

    +$47.3K

    Apr 29, 2026

    25,000 sh · $1.89

  • Lerner Neil

    Chief Accounting Officer

    +$28.4K

    Apr 29, 2026

    15,000 sh · $1.89

  • Schuetz Thomas J.

    Chief Executive Officer · Director

    +$21.1K

    May 27, 2025

    10,000 sh · $2.11

  • Gordon Carl L

    Director · 10% Owner

    −$5.7M

    Apr 09, 2025

    3,571,428 sh · $1.59

  • Anderman Jonathan

    Gen Counsel & Corporate Sec

    +$30.8K

    Apr 07, 2025

    20,000 sh · $1.54

  • Lerner Neil

    Chief Accounting Officer

    +$28.4K

    Apr 07, 2025

    20,000 sh · $1.42

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Don't check CMPX — let it ping you

Watch every insider filing the minute it clears the SEC

The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.

Compass Therapeutics, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.

Other companies insiders are buying now

Questions

Are CMPX insiders buying or selling?
Between Sep 24, 2026 and Sep 24, 2026, 1 Compass Therapeutics, Inc. insider made 1 open-market purchase worth $2.8K and no sales, a net purchase of $2.8K.
How much CMPX stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 4 Compass Therapeutics, Inc. insiders made 5 open-market purchases worth $155.9K and 1 sale worth $5.7M. In the four quarters to Jun 30, 2026: 2 purchases ($75.6K) and no sales. The largest purchase was Anderman Jonathan buying $47.3K on Apr 29, 2026. The largest sale was Gordon Carl L selling $5.7M on Apr 09, 2025.
What was the largest recent CMPX insider trade?
Lerner Neil (Chief Accounting Officer) bought $2.8K of CMPX stock on Sep 24, 2026 at about $1.14 a share.
When did an insider last buy CMPX shares?
The most recent open-market purchase on file is Lerner Neil (Chief Accounting Officer) buying $2.8K on Sep 24, 2026.
Where does CMPX insider trading data come from?
From the Form 4 filings Compass Therapeutics, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.